- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05208723
Addressing Stress Amongst Female Entrepreneurs in Addis Ababa, Ethiopia: a Pilot Study (DWMTS)
February 3, 2022 updated by: World Bank
Stress and Emotion Management Training for Female Entrepreneurs in Ethiopia
The overall objective of this study is to evaluate the impact of the "Doing What Matters in Times of Stress Guided Self-Help" handbook along with lay helper session on managing stress and emotion on mental distress and well-being.
If successful, the study will assess its impact on business performance among women entrepreneurs in Ethiopia.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The overall objective of this study is to evaluate the impact of the "Doing What Matters in Times of Stress Guided Self-Help Manual" on mental distress and if successful, see its impact on business performance among women entrepreneurs in Ethiopia.
The study will be conducted in Addis Ababa, Ethiopia.
A pilot randomized controlled trial (RCT) will be conducted to investigate the impact of the "Doing What Matters in Times of Stress Guided Self-Help Manual" intervention to reduce psychological distress and functional impairment among women entrepreneurs in Ethiopia.
The investigators will screen approximately1200 women over the phone and identify 200 eligible women for the study.
An in-person baseline survey will be conducted with the 200 eligible women and the participants will be randomized (using computer generated randomization) to either the doing what matters in times of stress self-help manual intervention (n=100) or wait list control (n=100).
This will be followed by 6 phone-based sessions over 6-8 weeks to review handbook materials for the intervention group only.
After six weeks, phone-based follow-up survey will be conducted with participants in both the intervention and control groups.
If the intervention is found to be effective in reducing distress or stress at follow-up assessment, then the baseline survey will be repeated at 6-9 months post intervention both for the intervention and control group participants.
Additionally, based on findings from the pilot study a larger sample of participants will be screened and enrolled (approximately 1000 women) and randomized to the intervention or wait-list control arm to be followed up at 6-9 months post intervention.
The primary outcomes for this study will be psychological distress.
Participants' performance on their businesses and self-esteem will be secondary outcomes for the study.
A generalized linear model with appropriate statistical specifications and accounting for baseline values and any imbalanced variables at baseline (where available) will be used to analyze the data.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Addis Ababa, Ethiopia
- PSI and World Bank, Ethiopia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age ≥18;
- Women entrepreneurs who obtained loan or business skills training from WEDP;
- Those who have plan to live in Addis Ababa in the next six months;
- Those who can read and speak Amharic and can understand the study questionnaire;
- Those who have capacity to provide informed consent;
- Score 8 or above on the Ethiopian adaptation of Kessler-6;
Exclusion Criteria:
- Kessler 6 score >20;
- Those who have recent or current suicidal thoughts or plans;
- Those who have limitation to understand the study questionnaire;
- Those who have not capacity to provide informed consent;
- Do not own a mobile phone;
- Not interested in receiving the intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stress and emotion management
A locally adapted self-help guidebook originally developed by the World Health Organization (WHO), 'Doing what matters in times of stress' for managing disruptive emotions and psychological distress, will be delivered to female entrepreneurs at their residence, followed by 5-6 phone calls from a trained mental health helper to reinforce the materials over a 6-week period.
The intervention is intended to help people manage their psychological distress associated with a range of adversities but is not intended for participants with severe mental health problems such as psychosis or imminent risk of suicide.
|
The handbook materials and lay helper scripts are based on principles of Acceptance and Commitment Therapy (ACT), and aims to enhance psychological flexibility.
Psychological flexibility reflects how a person adapts to fluctuating situational demands, reconfigures mental resources, shifts perspective, and balances competing needs.
ACT teaches alternative methods to accommodate difficult thoughts and feelings, primarily through mindfulness techniques.
At the same time, ACT also focuses on guiding participants to live in ways consistent with their personal values.
Other Names:
|
|
No Intervention: Control group
No intervention.
May receive intervention post study if findings are indicative of any benefit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental Distress using the Kessler Psychological Distress Scale (K-6)
Time Frame: 4-6 weeks post intervention
|
Minimum value of 0 and a maximum value of 24.
Higher scores indicate high levels of psychological distress (worse outcome)
|
4-6 weeks post intervention
|
|
Mental Distress using the Kessler Psychological Distress Scale (K-6)
Time Frame: 6-9 months post intervention
|
Minimum value of 0 and a maximum score of 24.
Higher scores indicate high levels of psychological distress (worse outcome)
|
6-9 months post intervention
|
|
Depression using the Patient Health Questionnaire (PHQ-9)
Time Frame: 4-6 weeks post intervention
|
Minimum score 0 and a maximum score of 27.
Higher scores indicate increased levels of depressive symptoms (worse outcome).
|
4-6 weeks post intervention
|
|
Depression using the Patient Health Questionnaire (PHQ-9)
Time Frame: 6-9 months post intervention
|
Minimum score 0 and a maximum score of 27.
Higher scores indicate increased levels of depressive symptoms (worse outcome).
|
6-9 months post intervention
|
|
Stress using the Perceived Stress Scale
Time Frame: 4-6 weeks post intervention
|
Minimum score of 0 and a maximum of 40.
Higher scores indicate high levels of perceived stress (worse outcome).
Investigators will reverse code items 4,5, 7 and 8
|
4-6 weeks post intervention
|
|
Stress using the Perceived Stress Scale
Time Frame: 6-9 months post intervention
|
Minimum score of 0 and a maximum of 40.
Higher scores indicate high levels of perceived stress (worse outcome).
Investigators will reverse code items 4,5, 7 and 8
|
6-9 months post intervention
|
|
Self-reported Business outcomes
Time Frame: 6-9 months post intervention
|
Self-reported past month profits in local currency
|
6-9 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported Business outcomes
Time Frame: 4-6 weeks post intervention
|
Self-reported past month profits in local currency
|
4-6 weeks post intervention
|
|
Self-reported Business Closure
Time Frame: 4-6 weeks post intervention
|
Self-reported business closure
|
4-6 weeks post intervention
|
|
Self-reported Business Closure
Time Frame: 6-9 months post intervention
|
Self-reported business closure
|
6-9 months post intervention
|
|
Self-reported number of recent hires
Time Frame: 4-6 weeks post intervention
|
Average self-reported number of employees hired in the past month
|
4-6 weeks post intervention
|
|
Self-reported number of employees
Time Frame: 6-9 months post intervention
|
Average self-reported number of employees
|
6-9 months post intervention
|
|
Self-Esteem using the Rosenberg Self-esteem Scale
Time Frame: 4-6 weeks post intervention
|
Minimum score 10 and a maximum score of 40.
Investigators will reverse code items 3,5,8,9 and 10 .
Higher scores indicate high levels of self-esteem (better outcome)
|
4-6 weeks post intervention
|
|
Self-Esteem using the Rosenberg Self-esteem Scale
Time Frame: 6-9 months post intervention
|
Minimum score 10 and a maximum score of 40.
Investigators will reverse code items 3,5,8,9 and 10.
Higher scores indicate high levels of self-esteem (better outcome)
|
6-9 months post intervention
|
|
World Health Organisation- Five Well-Being Index (WHO-5)
Time Frame: 4-6 weeks post intervention
|
Minimum score of 0 and a maximum of 25.
Higher scores mean better wellbeing (better outcome).
Scores are transformed to 0-100 (by multiplying by 4.
|
4-6 weeks post intervention
|
|
World Health Organisation- Five Well-Being Index (WHO-5)
Time Frame: 6-9 months post intervention
|
Minimum score of 0 and a maximum of 25.
Higher scores mean better wellbeing (better outcome).
Scores are transformed to 0-100 (by multiplying by 4.
|
6-9 months post intervention
|
|
Functional Impairment using the World Health Organization Disability Assessment Schedule (WHODAS-2.0 -12 item version)
Time Frame: 6-9 months post intervention
|
Minimum score of 12 and a maximum of 60.
Higher scores indicate high levels of disability (worse outcome)
|
6-9 months post intervention
|
|
Functional Impairment using the World Health Organization Disability Assessment Schedule (WHODAS-2.0 -12 item version)
Time Frame: 4-6 weeks post intervention
|
Minimum score of 12 and a maximum of 60.
Higher scores indicate high levels of disability (worse outcome)
|
4-6 weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Naira Kalra, PhD, World Bank
- Principal Investigator: Adiam Hailemicheal, MSc, World Bank
- Principal Investigator: Kassahun Habtamu Mekonnen, PhD, Addis Ababa University
- Principal Investigator: Medhin Selamu Tegegn, PhD, College of health science, Addis Ababa University, Ethiopia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 17, 2021
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
December 20, 2021
First Submitted That Met QC Criteria
January 12, 2022
First Posted (Actual)
January 26, 2022
Study Record Updates
Last Update Posted (Actual)
February 15, 2022
Last Update Submitted That Met QC Criteria
February 3, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DWMTS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All unidentified IPD that underlie results in a publication will be shared if doing so is approved by the Institutional Review Board and clears privacy and security requirements set by the World Bank microdata portal.
IPD Sharing Time Frame
Post study in 2023.
Will be shared for at least 2 years.
IPD Sharing Access Criteria
Publicly available. Use of the dataset must be acknowledged using a citation which would include:
- the Identification of the Primary Investigator
- the title of the survey (including country, acronym and year of implementation)
- the survey reference number
- the source and date of download
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Hacettepe UniversityCompletedStressTurkey (Türkiye)
-
Baylor UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Universität Duisburg-EssenRecruitingStress | Burnout | Burnout Syndrome | Stress ResilienceGermany
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingPsychological Stress | Social Interaction
Clinical Trials on Stress and emotion management
-
Ohio State UniversityCompletedStress, PsychologicalUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
University Hospital, GrenobleFrench National Society of Gastroenterology; Association François AupetitCompletedIrritable Bowel Syndrome | Ulcerative Colitis | Inflammatory Bowel Disease (IBD) | Crohn's Disease(CD)France
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)CompletedStress, Psychological | Stress, PhysiologicalUnited States
-
Oslo University HospitalNorwegian Cancer SocietyActive, not recruitingCancer | Stress, PsychologicalNorway
-
University of Colorado, DenverCompleted
-
Assistance Publique Hopitaux De MarseilleUnknownDepression and EpilepsyFrance
-
Amit SoodCompleted
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis 2United States
-
McGill UniversityCompletedStress | Well-being | Mindfulness | Adherence | Coping | Behaviour Change | Digital InterventionCanada